LONDON (Reuters) – Phase three trials involving more than 32,000 volunteers across all age groups, conducted in the U.S., Chile and Peru have shown that COVID-19 AstraZeneca vaccine is safe and highly effective, the University of Oxford said on Monday.
“These results are great news as they show the remarkable efficacy of the vaccine in a new population and are consistent with the results from Oxford-led trials,” Andrew Pollard, who runs the Oxford Vaccine Group, said.
(Reporting by Michael Holden; editing by Guy Faulconbridge)
